choline has been researched along with tanespimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotedia, K; Koutcher, JA; Le, HC; Lupu, M; Rosen, N; Solit, D | 1 |
| Brandes, AH; Ronen, SM; Ward, CS | 1 |
2 other study(ies) available for choline and tanespimycin
| Article | Year |
|---|---|
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.
Topics: Androgens; Benzoquinones; Biomarkers, Tumor; Cell Line, Tumor; Choline; Humans; Lactams, Macrocyclic; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Protons | 2009 |
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Topics: Antigens, CD; Antineoplastic Agents; Benzoquinones; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Choline; Female; Gene Expression Regulation, Neoplastic; Glycerylphosphorylcholine; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Magnetic Resonance Spectroscopy; MCF-7 Cells; Membrane Transport Proteins; Organic Cation Transport Proteins; Phospholipases A2; Phosphorylcholine | 2010 |